HiFiBiO Therapeutics
Phase 1HiFiBiO Therapeutics is pioneering curative immunotherapies for patients with high unmet medical needs. The company is targeting the root cause of disease through its unique Drug Intelligence Science (DIS®) platform. DIS® enables the deep understanding of cellular pathology across various diseases through proprietary single cell technology and AI/ML analytics. This platform is being deployed in target discovery, antibody selection, and predictive biomarker identification to achieve enhanced c...
About
HiFiBiO Therapeutics is pioneering curative immunotherapies for patients with high unmet medical needs. The company is targeting the root cause of disease through its unique Drug Intelligence Science (DIS®) platform. DIS® enables the deep understanding of cellular pathology across various diseases through proprietary single cell technology and AI/ML analytics. This platform is being deployed in target discovery, antibody selection, and predictive biomarker identification to achieve enhanced c...
Funding History
3Total raised: $112.5M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile